Medicine & Life Sciences
Histoplasmosis
100%
Colombia
68%
Cryptococcosis
67%
Cryptococcus neoformans
57%
Histoplasma
49%
Cryptococcus gattii
48%
HIV
47%
Mycoses
43%
Antigens
29%
Acquired Immunodeficiency Syndrome
28%
Candida
27%
Cryptococcus
27%
Paracoccidioides
26%
Fungi
25%
Virulence
24%
Genome
21%
Genetic Variation
21%
Infections
20%
Yeasts
19%
Fluconazole
18%
Genotype
14%
Paracoccidioidomycosis
14%
Multilocus Sequence Typing
14%
Immunoenzyme Techniques
14%
Latin America
13%
Sporotrichosis
13%
Immunoglobulin G
13%
Chrysosporium
13%
South Africa
13%
Guatemala
12%
Serum
12%
Peru
12%
Mitochondrial Genome
12%
Haplotypes
11%
Mortality
11%
Urine
11%
Coinfection
10%
Molecular Epidemiology
10%
Single Nucleotide Polymorphism
10%
Voriconazole
10%
Onygenales
10%
Blastomyces
9%
Cryptococcal Meningitis
9%
Fungal Antibodies
9%
Fungemia
9%
Tuberculosis
9%
Sporothrix
9%
Population
9%
Proteins
8%
Neglected Diseases
8%
Immunoglobulin M
8%
Antibodies
8%
Meningoencephalitis
8%
Flucytosine
8%
Nanopore Sequencing
8%
Genes
8%
Trehalase
8%
Candida albicans
8%
Sensitivity and Specificity
8%
Fungal Drug Resistance
7%
Mitochondrial DNA
7%
Anidulafungin
7%
Azoles
7%
Guidelines
7%
Therapeutics
7%
Coccidioidomycosis
7%
Opportunistic Infections
6%
Echinocandins
6%
Circulating MicroRNA
6%
Caspofungin
6%
Radioimmunotherapy
6%
Cross Reactions
6%
Candida glabrata
6%
Dental Clinics
6%
Itraconazole
6%
Nucleotide Motifs
6%
Child
6%
Immunoglobulin A
6%
Immunocompromised Host
6%
Polymerase Chain Reaction
6%
Synthetic Vaccines
6%
Mycology
6%
Human Genetics
5%
Argentina
5%
Disease Outbreaks
5%
T-Lymphocyte Epitopes
5%
Aspergillosis
5%
Antifungal Agents
5%
Candida parapsilosis
5%
Restriction Fragment Length Polymorphisms
5%
Amphotericin B
5%
Lung
5%
Highly Active Antiretroviral Therapy
5%
Mycetoma
5%
Dust
5%
South America
5%
Larva
5%
Real-Time Polymerase Chain Reaction
5%
Pleural Effusion
5%
Agriculture & Biology
histoplasmosis
60%
Cryptococcus neoformans
34%
cryptococcosis
32%
Cryptococcus gattii
31%
Histoplasma
22%
Latin America
18%
molecular epidemiology
17%
mycoses
16%
Cryptococcus (Tremellomycetes)
15%
Colombia
15%
Human immunodeficiency virus
15%
multilocus sequence typing
14%
assays
12%
meta-analysis
11%
Galleria mellonella
10%
genetic variation
10%
virulence
9%
tuberculosis
9%
fluconazole
9%
enzyme immunoassays
9%
acquired immunodeficiency syndrome
9%
antigens
9%
Guatemala
8%
HIV infections
8%
Paracoccidioides
8%
urine
8%
itraconazole
8%
coccidioidomycosis
8%
meningoencephalitis
6%
yeasts
6%
aspergillosis
6%
genotype
6%
secondary infection
6%
retrospective studies
6%
mixed infection
6%
Amazonia
6%
therapeutics
6%
confidence interval
5%
education programs
5%
risk factors
5%
limonene
5%
Candida albicans
5%
Peru
5%
Earth & Environmental Sciences
human immunodeficiency virus
35%
assay
18%
infection
14%
virulence
13%
tuberculosis
11%
antigen
11%
hospital
9%
surveillance
9%
mortality
8%
pathogenicity
7%
detection
7%
genotype
7%
chemotherapy
6%
risk factor
6%
species complex
6%
Americas
5%
rearing
5%
serum
5%
genome
5%
confidence interval
5%
meta-analysis
5%
therapy
5%
urine
5%
acquired immune deficiency syndrome
5%